ReviewFrontiers in pharmacology2025
Epigenetic programming reshapes innate immune memory: decoding the molecular imprint of gouty inflammation.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The gut-joint axis in gout: microbial outer membrane vesicles and mFrontiers in immunology · 2026Review
- Immune signaling as a determinant of cellular identity and tissue function.Frontiers in immunology · 2026Review
- Spatiotemporal immune gradients in gout: immune response-driven activation of the NLRP3-IL-1β axis and its transition to trained immunity.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gout is an inflammatory joint disease caused by abnormal uric acid metabolism, characterized by the deposition of urate crystals in joints and surrounding tissues, leading to acute or chronic inflammatory responses. The etiology and pathogenesis of gout are complex, and there is currently a lack of ideal therapeutic drugs and treatment strategies. Epigenetic modifications influence and regulate gene function and characteristics through mechanisms such as DNA methylation, histone modifications, chromatin remodeling, and non-coding RNA, thereby exerting significant effects on the physiological and pathological states of the body. Recently, epigenetic modifications and trained immunity in gout have garnered increasing research interest. Epigenetic modification-mediated trained immunity represents a frontier area in the study of gout pathogenesis. This review summarizes the latest findings on the role and regulatory mechanisms of epigenetic modifications in the development of gout, as well as the role of epigenetic remodeling-mediated trained immunity in gout and the potential applications of epigenetic intervention strategies in gout, providing new insights into the relationship between persistent inflammation, epigenetics, and innate immune memory in gout.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.